New Opportunities and Cautionary Insights about Decentralizing and Deglobalizing Clinical Trials During the Great Lockdown
Authors
Dunlap, DeniseSantos, Roberto S.
McManus, David D.
Buchholz, Bryan
Hafer, Nathaniel
Picard, MaryAnn
UMass Chan Affiliations
Program in Molecular MedicineUMass Center for Clinical and Translational Science
Department of Medicine, Division of Cardiovascular Medicine
Document Type
Journal ArticlePublication Date
2020-11-03Keywords
clinical trialscovid-19
decentralization
deglobalization
emerging technologies
healthcare
UMCCTS funding
Clinical Trials
Infectious Disease
International Business
International Public Health
Technology and Innovation
Virus Diseases
Metadata
Show full item recordAbstract
The 2020s began with a rare coronavirus (COVID-19) disaster, which led to a pandemic-induced recession and Great Lockdown. In response, there has been a worldwide mobilization of resources to detect, treat, and cure the virus. Some policymakers are advocating for the repatriation of globally distributed healthcare know-how. Without a cure for COVID-19, the ambiguity concerning how coronavirus-related policies will impact international business remains unclear. Through a multi-method approach, our study sheds light on two key healthcare industry trends: decentralization and deglobalization of clinical trials. We offer actionable strategies to not only mitigate these challenges, but also to take advantage of their new opportunities.Source
Dunlap D, Santos RS, McManus DD, Buchholz BO, Hafer NS, Picard M. New Opportunities and Cautionary Insights about Decentralizing and Deglobalizing Clinical Trials During the Great Lockdown. AIB Insights. 2020 Nov 3;20(3):10.46697/001c.17692. doi: 10.46697/001c.17692. PMID: 34413924; PMCID: PMC8372191. Link to article on publisher's site
DOI
10.46697/001c.17692Permanent Link to this Item
http://hdl.handle.net/20.500.14038/27484PubMed ID
34413924Related Resources
Rights
This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC-BY-4.0). View this license’s legal deed at http://creativecommons.org/licenses/by/4.0 and legal code at http://creativecommons.org/licenses/by/4.0/legalcode for more information.Distribution License
http://creativecommons.org/licenses/by/4.0/ae974a485f413a2113503eed53cd6c53
10.46697/001c.17692
Scopus Count
Except where otherwise noted, this item's license is described as This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC-BY-4.0). View this license’s legal deed at http://creativecommons.org/licenses/by/4.0 and legal code at http://creativecommons.org/licenses/by/4.0/legalcode for more information.